Pharmacological Profile of Once-Weekly Injectable Semaglutide for Chronic Weight Management. Expert Review of Clinical Pharmacology
Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose of NN2211, a long-acting glucagon-like peptide 1 derivative, in healthy male subjects
This targeted approach has shown promising results in improving body composition and overall health, highlighting the potential of Tesamorelin in clinical settings
What the research shows To explore whether GLP-1 medications are associated with increased risk of gastrointestinal conditions, a recent study compared over 200,000 individuals taking GLP-1 medications with a group taking other type 2 diabetes medications (1)
It is made from three amino acids - glycine, glutamine and cysteine - and, alongside its boost to immunity, also has a reputation for reducing pigmentation and evening skin tone